AMRX - Teva upgraded to Overweight at Piper Sandler on multiple expansion
2024-02-12 09:36:15 ET
More on Teva Pharmaceutical
- Teva Pharmaceutical Industries (TEVA) Q4 2023 Earnings Call Transcript
- Teva Pharmaceutical Industries Limited (TEVA) Presents at J.P. Morgan 42nd Annual Global Healthcare Conference (Transcript)
- Teva: 4 Key Drivers For A 2024 Revival (Upgraded Rating)
- Teva hits 52-week high on outlook, API divestment
- Biggest stock movers today: Plug Power, Paramount Global, Google parent Alphabet, and more